Three healthcare experts gave individual presentations on treatments for thyroid cancer, harmful substances that disrupt the body’s hormones, and rapid-reaction stroke treatment units during the Grand Rounds series of Weill Cornell Medicine – Qatar (WCM-Q).
WCM-Q graduate Dr Tania Jaber returned to Doha to give a presentation on radioactive iodine treatments for thyroid cancer, while Dr Thozhukat Sathyapalan, Professor of Endocrinology at the University of Hull, UK, explained that endocrine disruptors – chemicals that interfere with the body’s hormones – can cause a variety of conditions, including malignant tumors, birth defects and developmental disorders, among others.
Dr Matthew Fink, Louis & Gertrude Feil Professor and Department Chair of Neurology at Weill Cornell Medicine in New York, discussed how new mobile stroke treatment units are enabling earlier treatment of stroke victims and therefore dramatically improving long-term outcomes.
Dr Fink, who is also Associate Dean of Clinical Affairs, said that the focus is not just on survival, but on returning people to health and fully independent lives.
With stroke, the faster treatment is given, the higher the chances of full recovery. That is why these new mobile treatment units are so important.’
Mobile stroke treatment units are equipped with modern portable CT scanners to help mobile teams diagnose whether a stroke is ischemic (caused by a blood clot) or haemorrhagic (caused by a ruptured blood vessel) in order to quickly administer the correct treatment and then transport the patient to the most appropriate facility.
Dr Sathyapalan explained that a wide range of substances are understood to disrupt the endocrine (hormone) system, such as pesticides, certain types of plastic, heavy metals like lead and mercury, and bisphenol A (BPA), a chemical used in some types of plastic. Endocrine disruptors can adversely affect fertility and also pose a significant risk to unborn children and babies because their neural systems and organs are still growing and are highly sensitive to hormonal changes.
Dr Tania Jaber, who graduated from WCM-Q in 2011, undertook a residency in internal medicine at Cleveland Clinic in the United States, before taking a fellowship in endocrinology at the University of Texas and then an advanced fellowship in endocrine cancers at the University of Texas MD Anderson Cancer Centre.
In her Grand Rounds presentation Dr Jaber said that according to research, thyroid cancer is the second most common cancer in the GCC region and that between 1998 and 2002, Qatari females had the highest incidence of the disease at 13.5 individuals per 100,000, versus Kuwait with 7. Some thyroid cancers can be successfully treated with radioactive iodine therapy (RAI). Dr Jaber also discussed the different cases of thyroid cancer recommended for RAI treatment, new research into dosages, common side effects of RAI, and recommended frequency of follow-up scans.
Each activity was accredited locally by the Qatar Council for Healthcare Practitioners-Accreditation Department (QCHP-AD) and internationally by the Accreditation Council for Continuing Medical Education (ACCME).
You can check out more information about the WCM-Q Grand Rounds Series through this link.
